Silence Therapeutics (SLN) Cash & Current Investments: 2019-2025
Historic Cash & Current Investments for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $122.4 million.
- Silence Therapeutics' Cash & Current Investments rose 52.01% to $122.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.4 million, marking a year-over-year increase of 52.01%. This contributed to the annual value of $147.3 million for FY2024, which is 39.31% up from last year.
- Latest data reveals that Silence Therapeutics reported Cash & Current Investments of $122.4 million as of Q3 2025, which was down 34.43% from $186.6 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Cash & Current Investments ranged from a high of $208.1 million in Q1 2025 and a low of $37.2 million during Q2 2023.
- For the 3-year period, Silence Therapeutics' Cash & Current Investments averaged around $118.3 million, with its median value being $122.4 million (2025).
- As far as peak fluctuations go, Silence Therapeutics' Cash & Current Investments skyrocketed by 693.15% in 2021, and later crashed by 42.73% in 2023.
- MRQ analysis of 5 years shows Silence Therapeutics' Cash & Current Investments stood at $99.1 million in 2021, then plummeted by 35.14% to $64.3 million in 2022, then soared by 64.49% to $105.8 million in 2023, then soared by 39.31% to $147.3 million in 2024, then decreased by 16.95% to $122.4 million in 2025.
- Its Cash & Current Investments stands at $122.4 million for Q3 2025, versus $186.6 million for Q2 2025 and $208.1 million for Q1 2025.